Likewise, CD8+ T cells lacking Cbl-b or SHP-1 maintain resistance in vivo despite their accumulation in a highly suppressive tumor microenvironment, and can successfully control tumor outgrowth (152, 170). The gene discussed is CD8A; the disease is neoplasm.